Filter by: patients
Home > Community Treatment Reports and Side Effects > Carbidopa-Levodopa Treatment Report
What is Carbidopa-Levodopa?

Levodopa is a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 1459 359 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Stiffness/Spasticity 76 22 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Tremor 56 26 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Slowness 46 17 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Other 43 14 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
MSA (Multiple System Atrophy) 42 14 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell

See all 1792 patients currently taking Carbidopa-Levodopa

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 24
Moderate
 118
Mild
 147
None
 173

Commonly reported side effects, conditions, and hospitalizations associated with Carbidopa-Levodopa

Dyskinesia 65
Nausea 56
Drowsiness 32
Stomach upset 23
Vivid dreams 15
Sleep problems 15
See all 167 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Carbidopa-Levodopa. See all 205 dosages ►

  daily 25 mg daily 25 mg-100 mg daily 2 x 25 mg-100 mg daily 3 x 25 mg-100 mg daily 4 x 25 mg-100 mg daily 5 x 25 mg-100 mg daily 6 x 25 mg-100 mg daily 7 x 25 mg-100 mg daily 8 x 25 mg-100 mg daily
  55 Number of Patients: 55 43 Number of Patients: 43 167 Number of Patients: 167 75 Number of Patients: 75 258 Number of Patients: 258 160 Number of Patients: 160 77 Number of Patients: 77 124 Number of Patients: 124 30 Number of Patients: 30 64 Number of Patients: 64  

Reported Stop Reasons

Why Patients Stopped Taking Carbidopa-Levodopa (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 86   Doctor's advice: 37%
Did not seem to work 60   Did not seem to work: 26%
Other 45   Other: 20%
Side effects too severe 36   Side effects too severe: 16%
Personal research 20   Personal research: 9%
Course of treatment ended 14   Course of treatment ended: 6%
Not indicated 9   Not indicated: 4%
Expense 3   Expense: 1%
Change in health plan coverage 1   Change in health plan coverage: 0%

See all 215 patients who’ve stopped taking Carbidopa-Levodopa

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Carbidopa-Levodopa

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Carbidopa-Levodopa

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Carbidopa-Levodopa

Always
 336 73%
Usually
 102 22%
Sometimes
 11 2%
Never
 13 3%

Burden

Difficulty being on treatment

Burden of Carbidopa-Levodopa

Very
 17 4%
Somewhat
 75 16%
A little
 109 24%
Not at all
 261 56%

Cost

Paid out of pocket

Cost of Carbidopa-Levodopa

$200+
 4 1%
$100-199
 9 3%
$50-99
 18 6%
$25-49
 48 15%
< $25
 237 75%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.